Suzhou, CN Breaking News Headlines Today

News about Suzhou, China

Stay current with all the latest and breaking news about Suzhou, China, compare headlines and perspectives between news sources on stories happening today. In total, 58 stories have been published about Suzhou, China which Ground News has aggregated in the past 3 months.

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study

89% Center coverage: 9 sources

Suzhou, China · Suzhou See the Story

Tesla Eyes $2.9 Billion Solar Deal With China To Power Massive 100 GW Expansion

Tesla · Suzhou Read Article

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016

100% Right coverage: 1 sources

Suzhou, China · Suzhou Read Article

Welcome to the Villa Where Traditional Chinese Style Meets Western Minimalism

100% Left coverage: 1 sources

Suzhou, China · Suzhou Read Article

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/VEGFR2 Bispecific ADC JSKN027

100% Right coverage: 1 sources

Suzhou, China · Suzhou Read Article

Adagene (ADAG) to Release Earnings on Monday

100% Center coverage: 1 sources

Suzhou, China · Suzhou Read Article

BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards - PressReach

Innovation · Suzhou See the Story

It Sounds Strange, but Science Confirms It: Bee Guts Demonstrate the Ecological Well-Being of a City

100% Right coverage: 1 sources

Suzhou, China · Suzhou Read Article

Alphamab Oncology Announces IND Application for Innovative EGFR/HER3 Dual Payload Bispecific ADC JSKN021 was Officially Accepted by CDE

100% Right coverage: 1 sources

Suzhou, China · Suzhou Read Article

Alphamab Oncology Appoints Dr. Hongwei Wang as Chief Technology Officer

100% Right coverage: 1 sources

Suzhou, China · Suzhou Read Article

News about Suzhou, China

News about Suzhou, China

Local News Publishers Too Big Arrow Icon

Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study

Tesla Eyes $2.9 Billion Solar Deal With China To Power Massive 100 GW Expansion

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016

Welcome to the Villa Where Traditional Chinese Style Meets Western Minimalism

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/VEGFR2 Bispecific ADC JSKN027

Adagene (ADAG) to Release Earnings on Monday

BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards - PressReach

It Sounds Strange, but Science Confirms It: Bee Guts Demonstrate the Ecological Well-Being of a City

Alphamab Oncology Announces IND Application for Innovative EGFR/HER3 Dual Payload Bispecific ADC JSKN021 was Officially Accepted by CDE

Alphamab Oncology Appoints Dr. Hongwei Wang as Chief Technology Officer

Local News Publishers Too Big Arrow Icon

Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study

Tesla Eyes $2.9 Billion Solar Deal With China To Power Massive 100 GW Expansion

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016

Welcome to the Villa Where Traditional Chinese Style Meets Western Minimalism

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/VEGFR2 Bispecific ADC JSKN027

Adagene (ADAG) to Release Earnings on Monday

BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards - PressReach

It Sounds Strange, but Science Confirms It: Bee Guts Demonstrate the Ecological Well-Being of a City

Alphamab Oncology Announces IND Application for Innovative EGFR/HER3 Dual Payload Bispecific ADC JSKN021 was Officially Accepted by CDE

Alphamab Oncology Appoints Dr. Hongwei Wang as Chief Technology Officer

Local News Publishers

Local News Publishers